Chart calendar CureVac N.V.

61448.JE6XuUFG5pDj7xnuINElPBHuu2jQ96YfFiToTtm1bdI.UzT22y4snueKn0CcTKRmD0i4y1GkvfZ9YXy_C675NIFdfP6UCiOh4LGwWA~50c424ecaa8ccc99ce4898f602e1d1ba

Upcoming events on CureVac N.V.

24/06/2025 13:00 Annual General Meeting
13/08/2025 Q2 2025 Earnings Release (Projected)
17/11/2025 Q3 2025 Earnings Release (Projected)
28/04/2026 Q4 2025 Earnings Release (Projected)
26/05/2026 Q1 2026 Earnings Release (Projected)

Past events on CureVac N.V.

20/05/2025 12:00 Q1 2025 Earnings Release
10/04/2025 14:00 Q4 2024 Earnings Call
10/04/2025 12:12 Q4 2024 Earnings Release
01/04/2025 Van Lanschot Kempen Life Sciences Conference
26/03/2025 Goldman Sachs Biopharma Innovation Summit
10/03/2025 14:40 Leerink Partners Global Healthcare Conference
14/11/2024 18:44 International mRNA Health Conference
14/11/2024 14:38 International mRNA Health Conference
13/11/2024 18:00 Guggenheim Securities Healthcare Innovation Conference
12/11/2024 14:00 Q3 2024 Earnings Call
12/11/2024 12:00 Q3 2024 Earnings Release
08/11/2024 Society for Immunotherapy of Cancer Meeting - Abstract No:380
08/11/2024 Society for Immunotherapy of Cancer Meeting - Abstract No:370
07/11/2024 Society for Immunotherapy of Cancer Meeting - Abstract No:697
15/09/2024 08:00 European Society for Medical Oncology Meeting - Abstract No: 22P
13/09/2024 13:00 European Society for Medical Oncology Meeting - Abstract No: 440O
15/08/2024 12:06 Q2 2024 Earnings Release
24/06/2024 13:00 Annual General Meeting
11/06/2024 Goldman Sachs Global Healthcare Conference
05/06/2024 12:30 Jefferies Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million EUR
Released
Forecast
Spread
67,4
73,4
-8.19%
53,8
66,3
-18.8%
535
524
2.1%

69,1


85,6


144

EBITDA
Million EUR
Released
Forecast
Spread
-226
-190
-19.04%
-251
-185
-35.3%
196
218
-9.68%

-99,6


-96,6


-42,2

EBIT
Million EUR
Released
Forecast
Spread
-249
-196
-27.26%
-274
-210
-30.42%
178
192
-7.54%

-98,0


-97,0


-14,2

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-249
-205
-21.25%
-260
-186
-39.71%
190
197
-3.38%

-81,5


-101


-40,6

Net income
Million EUR
Released
Forecast
Spread
-249
-199
-24.98%
-260
-199
-30.71%
162
176
-8.02%

-103


-112


-49,8

EPS
EUR
Released
Forecast
Spread
-1,32
-1,04
-26.45%
-1,18
-0,95
-24.78%
0,72
0,57
26.29%

-0,46


-0,49


-0,22

Announcement Date25/04/2324/04/2410/04/25-

Quarterly results

Fiscal PeriodMarch 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million EUR
Released
Forecast
Spread
16,5
16,0
3.27%
22,6
29,1
-22.29%
12,4
12,9
-4%
14,4
4,91
193.94%
494
138
257.05%
14,5
20,6
-29.55%
0,89
3,34
-73.25%

3,34


34,6


32,6

EBIT
Million EUR
Released
Forecast
Spread
-54,0
-52,2
-3.5%
-88,0
-36,0
-144.59%
-73,3
-57,4
-27.72%
-73,6
-58,2
-26.6%
368
341
7.9%
-43,8
5,99
-830.91%
-54,7
-47,3
-15.81%

-43,6


21,0


13,0

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-48,7
-52,0
6.35%
-86,5
-28,0
-208.93%
-69,9
-55,0
-27.07%
-71,2


371
128
188.54%
-38,6
24,2
-259.25%
-51,7
-45,5
-13.41%

-41,9


22,6


14,9

Net income
Million EUR
Released
Forecast
Spread
-48,7
-37,3
-30.51%
-86,7
-25,3
-242.5%
-70,6
-48,8
-44.72%
-72,5
-53,0
-36.87%
338
328
3.11%
-32,8
6,86
-577.62%
-52,1
-41,1
-26.63%

-38,9


3,96


4,36

EPS
EUR
Released
Forecast
Spread
-0,22
-0,24
7.9%
-0,39
-0,18
-112.38%
-0,31
-0,24
-29.16%
-0,32
-0,30
-6.26%
1,50
0,42
254.72%
-0,14
-0,19
26.55%
-0,23
-0,18
-25.82%

-0,18


-0,03


-0,02

Announcement Date14/11/2324/04/2423/05/2415/08/2412/11/2410/04/2520/05/25---

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise